运动训练计划和β受体阻滞剂治疗对自然获得性慢性二尖瓣疾病犬生活质量短期随访

数据集获取（Figshare）

• 源站标题：Short-term follow-up of exercise training program and beta-blocker treatment on quality of life in dogs with naturally acquired chronic mitral valve disease
• DOI：10.6084/m9.figshare.7899083.v1
• 发布日期：2019-03-27
• 文件数：6 个
• 文件总体积：291.06 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Short-term_follow-up_of_exercise_training_program_and_beta-blocker_treatment_on_quality_of_life_in_dogs_with_naturally_acquired_chronic_mitral_valve_disease/7899083

命令行下载

curl -L -o "1414-431X-bjmbr-1414-431X20144568-gf001.jpg" "https://ndownloader.figshare.com/files/14711927"
curl -L -o "1414-431X-bjmbr-1414-431X20144568-gf002.jpg" "https://ndownloader.figshare.com/files/14711933"
curl -L -o "1414-431X-bjmbr-1414-431X20144568-gf003.jpg" "https://ndownloader.figshare.com/files/14711936"
curl -L -o "1414-431X-bjmbr-1414-431X20144568-gt001.jpg" "https://ndownloader.figshare.com/files/14711939"
curl -L -o "1414-431X-bjmbr-1414-431X20144568-gt002.jpg" "https://ndownloader.figshare.com/files/14711942"
curl -L -o "1414-431X-bjmbr-1414-431X20144568-gt003.jpg" "https://ndownloader.figshare.com/files/14711945"

文件清单

• 1414-431X-bjmbr-1414-431X20144568-gf001.jpg（22.08 KB）
• 1414-431X-bjmbr-1414-431X20144568-gf002.jpg（36.20 KB）
• 1414-431X-bjmbr-1414-431X20144568-gf003.jpg（35.77 KB）
• 1414-431X-bjmbr-1414-431X20144568-gt001.jpg（56.85 KB）
• 1414-431X-bjmbr-1414-431X20144568-gt002.jpg（42.48 KB）
• 1414-431X-bjmbr-1414-431X20144568-gt003.jpg（97.68 KB）

文件总体积 291.06 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

This study aimed to evaluate the effects of carvedilol treatment and a regimen of supervised aerobic exercise training on quality of life and other clinical, echocardiographic, and biochemical variables in a group of client-owned dogs with chronic mitral valve disease (CMVD). Ten healthy dogs (control) and 36 CMVD dogs were studied, with the latter group divided into 3 subgroups. In addition to conventional treatment (benazepril, 0.3-0.5 mg/kg once a day, and digoxin, 0.0055 mg/kg twice daily), 13 dogs received exercise training (subgroup I; 10.3±2.1 years), 10 dogs received carvedilol (0.3 mg/kg twice daily) and exercise training (subgroup II; 10.8±1.7 years), and 13 dogs received only carvedilol (subgroup III; 10.9±2.1 years). All drugs were administered orally. Clinical, laboratory, and Doppler echocardiographic variables were evaluated at baseline and after 3 and 6 months. Exercise training was conducted from months 3-6. The mean speed rate during training increased for both subgroups I and II (ANOVA, P>0.001), indicating improvement in physical conditioning at the end of the exercise period. Quality of life and functional class was improved for all subgroups at the end of the study. The N-terminal pro-brain natriuretic peptide (NT-proBNP) level increased in subgroup I from baseline to 3 months, but remained stable after training introduction (from 3 to 6 months). For subgroups II and III, NT-proBNP levels remained stable during the entire study. No difference was observed for the other variables between the three evaluation periods. The combination of carvedilol or exercise training with conventional treatment in CMVD dogs led to improvements in quality of life and functional class. Therefore, light walking in CMVD dogs must be encouraged.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.7899083.v1（source: https://scielo.figshare.com/articles/dataset/Short-term_follow-up_of_exercise_training_program_and_beta-blocker_treatment_on_quality_of_life_in_dogs_with_naturally_acquired_chronic_mitral_valve_disease/7899083）。